Michael Alonso

Company: Bolt Biotherapeutics

Job title: Scientific Co-founder & Senior Vice President - Research

Seminars:

Structural Insights Into Next-Generation ISACs for Tumor-Specific Immune Activation 9:15 am

Discussing data demonstrating ISAC induced localized activation of innate immunity within the tumor microenvironment while minimizing systemic immune effects Preclinical validation of multiple tumor targets, including data from lead candidate BDC4182 in gastric and pancreatic cancers Overcoming challenges in TLR 7/8 Agonist payload conjugation chemistryRead more

day: Conference Day One